TATAA Biocenter, a leading global CRO for high-quality molecular analysis, announced the promotion of Sofia Adolfsson to Head of Bioinformatics and Scientific Officer.
TATAA Biocenter AB announces new leadership team to support long-term ambitions TATAA Biocenter AB (the “Company” or “TATAA”), a leading global CRO for high-quality molecular
TATAA Biocenter, a leading CRO of molecular analysis services, announces it has become a certified service provider for RealSeq Biosciences, a developer of innovative sequencing
TATAA Biocenter, a leading provider of high-quality molecular analysis services, announced today that it has become a certified Qualified Service Provider for HTG Molecular Diagnostics. This certification will enable TATAA to offer high-throughput, multiplex gene expression profiling to its customers, and expand its portfolio of molecular analysis services.
TATAA Biocenter has partnered with Universal Sequencing Technology Corporation (UST) to offer full-service solutions for Long Read Sequencing Applications using UST TELL-Seq Linked Read technology.
The LIMS has been set up specifically for the needs of TATAA Biocenter and will stand out to customers as a critical competitive differentiator. A tailored and unique system bringing many benefits to TATAA’s scientists and customers.
As part of a 320M SEK investment program in biological therapies, one research project will play a pivotal role in making Sweden a major leader in Advanced Therapeutic Medical Products (ATMPs) by 2030.
TATAA Biocenter, Europe’s leading provider of molecular analysis services, announced it is adding Stilla’s six-color naica® system to its digital PCR service offerings
Tataa Biocenter is partnering with Olink and Illumina to offer high performance proteomics with unprecedented throughput
TATAA Biocenter, an industry-leading nucleic acid analysis services provider, is excited to announce the opening of a Good Laboratory Practice (GLP) compliant facility in Gothenburg, Sweden. The new facility, which is set to open on December 3rd, 2021, will specialize in quality control (QC) analytics to better support the needs of gene and cell therapeutics.
TATAA Biocenter AB © 2023 All rights reserved
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
